LUXURGERY, New York, NY, USA.
Division of Plastic and Reconstructive Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
J Cosmet Dermatol. 2021 Jun;20(6):1655-1662. doi: 10.1111/jocd.14141. Epub 2021 Apr 18.
Clinical data on body contouring with injectable poly-L-lactic acid are sparsely reported in published literature. This study describes the lead author's clinical experience using injectable poly-L-lactic acid for body contouring in various anatomic locations.
Twenty consecutive patients undergoing body contouring treatments with poly-L-lactic acid were prospectively followed. All treatments were performed at a single clinic between February 2017 and February 2019. Treatment details such as reconstitution, injection volume and dosage were documented. Treatment response was assessed independently by patients and the treating physician. Adverse events were recorded.
Twenty patients (85% women) received injectable poly-L-lactic acid for body contouring treatments such as buttocks volumization, cellulite and skin quality treatment. In most patients (65%), poly-L-lactic acid was administered to correct postsurgical soft tissue deformities. Overall, patients had a mean of 5.1 treatment sessions in a mean of 1.4 anatomic locations. The most commonly treated anatomic locations were buttocks (58% of treatment sessions), thighs (20%) and abdomen (9%). Dosage and injection volume varied between patients depending on anatomic location and desired outcome. Most treatment sessions (86%) resulted in improvement of the treated area. Adverse events included bruising, oedema, numbness and tenderness. Nodule formation was recorded for one patient (5%).
According to the lead author's clinical experience, poly-L-lactic acid injection is well tolerated and can achieve good aesthetic outcomes when used for body contouring in appropriate patients. Preliminary data suggest that poly-L-lactic acid injection may be a viable nonsurgical technique for correcting postsurgical soft tissue deformities.
在已发表的文献中,有关可注射聚左旋乳酸(poly-L-lactic acid)进行身体塑形的临床数据很少。本研究描述了主要作者在各种解剖部位使用可注射聚左旋乳酸进行身体塑形的临床经验。
对 20 名连续接受聚左旋乳酸身体塑形治疗的患者进行前瞻性随访。所有治疗均于 2017 年 2 月至 2019 年 2 月在一家诊所进行。记录了治疗细节,如复溶、注射量和剂量。治疗反应由患者和治疗医生独立评估。记录不良事件。
20 名患者(85%为女性)接受了可注射聚左旋乳酸治疗,用于臀部体积增大、改善蜂窝组织炎和皮肤质地等身体塑形治疗。在大多数患者(65%)中,使用聚左旋乳酸治疗来纠正手术后的软组织畸形。总的来说,患者在平均 1.4 个解剖部位接受了平均 5.1 次治疗。接受治疗最多的解剖部位是臀部(58%的治疗)、大腿(20%)和腹部(9%)。根据解剖部位和预期效果,每位患者的剂量和注射量都有所不同。大多数治疗都改善了治疗区域(86%)。不良事件包括瘀伤、肿胀、麻木和压痛。一名患者(5%)出现结节形成。
根据主要作者的临床经验,聚左旋乳酸注射具有良好的耐受性,在适当的患者中用于身体塑形可获得良好的美学效果。初步数据表明,聚左旋乳酸注射可能是一种可行的非手术技术,可用于纠正手术后的软组织畸形。